Pacira BioSciences Inc. (PCRX) Business Metrics | Revenue Breakdown & Segment Analysis - Stocknear

Pacira BioSciences Inc.

NASDAQ: PCRX · Real-Time Price · USD
24.84
0.26 (1.06%)
At close: Oct 03, 2025, 3:59 PM
24.84
0.00%
After-hours: Oct 03, 2025, 04:10 PM EDT

Bupivacaine Liposome Injectable Suspension Revenue

History

Quarter Value Change Growth
Jun 30, 2025 508K -2.1M -80.49%
Mar 31, 2025 2.6M 2.6M n/a
Dec 31, 2024 0 -1.64M -100.00%
Sep 30, 2024 1.64M -1.51M -47.91%
Jun 30, 2024 3.15M 629K +24.91%
Mar 31, 2024 2.52M 1.42M +129.34%
Dec 31, 2023 1.1M 243K +28.32%
Sep 30, 2023 858K 163K +23.45%
Jun 30, 2023 695K 7K +1.02%
Mar 31, 2023 688K -319K -31.68%
Dec 31, 2022 1.01M -1.95M -65.95%
Sep 30, 2022 2.96M 2M +209.31%
Jun 30, 2022 956K -600K -38.56%
Mar 31, 2022 1.56M -125.23M -98.77%
Sep 30, 2021 126.79M -8.07M -5.99%
Jun 30, 2021 134.86M 16.13M +13.58%
Mar 31, 2021 118.74M -11.03M -8.50%
Dec 31, 2020 129.76M 12.88M +11.01%
Sep 30, 2020 116.89M 41.67M +55.40%
Jun 30, 2020 75.22M -29.53M -28.19%
Mar 31, 2020 104.75M -17.1M -14.03%
Dec 31, 2019 121.85M 17.5M +16.77%
Sep 30, 2019 104.35M 2.53M +2.48%
Jun 30, 2019 101.82M 11.21M +12.37%
Mar 31, 2019 90.61M -3.81M -4.03%
Dec 31, 2018 94.42M 12.2M +14.83%
Sep 30, 2018 82.23M 1.8M +2.23%
Jun 30, 2018 80.43M 6.4M +8.64%
Mar 31, 2018 74.03M n/a n/a